Search results for "precision"

showing 10 items of 448 documents

Classification of patients with bipolar disorder using k-means clustering.

2019

Introduction Bipolar disorder (BD) is a heterogeneous disorder needing personalized and shared decisions. We aimed to empirically develop a cluster-based classification that allocates patients according to their severity for helping clinicians in these processes. Methods Naturalistic, cross-sectional, multicenter study. We included 224 subjects with BD (DSM-IV-TR) under outpatient treatment from 4 sites in Spain. We obtained information on sociodemography, clinical course, psychopathology, cognition, functioning, vital signs, anthropometry and lab analysis. Statistical analysis: k-means clustering, comparisons of between group variables, and expert criteria. Results and discussion We obtain…

MaleBipolar DisorderPsychometricsSocial SciencesSeverity of Illness IndexMedicine and Health SciencesMedicinePsychologyCluster AnalysisPrecision MedicineCognitive ImpairmentMetabolic SyndromeMultidisciplinaryCognitive NeurologyQRCognitionMiddle AgedNeurologyMedicineFemalePsychopathologyClinical psychologyResearch ArticleAdultPsychometricsScienceCognitive NeuroscienceQuality of life (healthcare)NeuropsychologySeverity of illnessMental Health and PsychiatryHumansCognitive skillBipolar disorderNeuropsychological Testingbusiness.industryMood DisordersCognitive PsychologyConstruct validityBiology and Life SciencesReproducibility of Resultsmedicine.diseaseHealth CareCross-Sectional StudiesSpainMetabolic DisordersQuality of LifeCognitive SciencebusinessNeuroscience
researchProduct

Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.

2013

Several pathologies affect human prostate, such as prostate cancer (PC), which is the most common non-skin malignant cancer in Western male populations. A complex interaction between genetic and environmental factors (i.e. infectious agents, dietary carcinogens) and hormonal imbalances has been reported to have a fundamental role in PC pathophysiology by evoking chronic inflammation. Thus, chronic inflammation drives prostate carcinogenesis and neoplastic progression. No adequate biomarkers exist until now to guide PC prognosis and treatment. Accordingly, the research has particularly focused its attention on genetic variants in genes, codifying molecules of signaling innate immune/inflamma…

MaleCancer ResearchSNPBioinformaticsTranslational Research BiomedicalProstate cancersex steroid and inflammatory networkRisk FactorsmedicineSettore MED/05 - Patologia ClinicaHumansGenetic Predisposition to DiseaseGenetic riskPrecision MedicineGonadal Steroid HormonesMolecular BiologyAllelesSettore MED/04 - Patologia GeneraleInflammationPolymorphism Geneticbusiness.industryrisk profileCancerProstatic NeoplasmsTranslation (biology)prostate cancermedicine.diseasePathophysiologypersonalized PC medicineCell Transformation NeoplasticImmunologygenetic biomarkerDisease ProgressionMolecular MedicinebusinessSignal TransductionCancer gene therapy
researchProduct

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor sampl…

2019

[Background] Approximately 30% of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. We have analyzed the clinical utility of next-generation sequencing (NGS) of cell-free circulating tumor DNA (ctDNA) in patients with inadequate tumor samples for tissue genotyping. [Patients and methods] We conducted the study in a multi-institutional prospective cohort of clinically unselected patients with advanced-stage lung adenocarcinomas with insufficient tissue for EGFR, ALK or ROS1 genotyping across 12 Spanish institutions (n = 93). ctDNA NGS was carried out by Guardant Health (Guardant360, Redwood City, CA), using a h…

MaleLung adenocarcinoma0301 basic medicineOncologyLung NeoplasmsCirculating Tumor DNA0302 clinical medicineco-occurring genomic alterationsGenotypeProspective StudiesNeoplasm MetastasisPrecision MedicineStage (cooking)Prospective cohort studyInsufficient tissueAged 80 and overactionable genomic alterationsHazard ratioHigh-Throughput Nucleotide SequencingDNA NeoplasmGenomicsinsufficient tissueHematologyMiddle AgedActionable genomic alterationsPrognosisSurvival Ratemedicine.anatomical_structureOncology030220 oncology & carcinogenesisFemaleAdultmedicine.medical_specialtydigital next-generation sequencingAdenocarcinoma of Lung03 medical and health sciencesProto-Oncogene ProteinsInternal medicineBiomarkers TumormedicineROS1HumansLung cancerGenotypingAgedDigital next-generation sequencingLungGenome Humanbusiness.industryctDNACo-occurring genomic alterationslung adenocarcinomamedicine.disease030104 developmental biologyMutationbusinessFollow-Up StudiesAnnals of Oncology
researchProduct

Brief Acceptance and Commitment Therapy for Fibromyalgia: Feasibility and Effectiveness of a Replicated Single-Case Design

2020

Objective. Overall, the literature on the effectiveness of psychological treatments in general and those for fibromyalgia in particular has been dominated by research designs that focus on large groups and explore changes on average, so the treatment impact at the individual level remains unclear. In this quasi-experimental, replicated single-case design, we will test the feasibility and effectiveness of a brief acceptance and committed therapy intervention using ecological momentary assessment supported by technology. Methods. ,e sample comprised 7 patients (3 in the individual condition and 4 in the group condition) who received a brief, 5-week psychological treatment. Patient evolution w…

MaleMedicine (General)050103 clinical psychologymedicine.medical_specialtyFibromyalgiaArticle Subjectmedia_common.quotation_subjectMEDLINESingle-subject designAcceptance and commitment therapylaw.invention03 medical and health sciencesR5-9200302 clinical medicineRandomized controlled triallawFibromyalgiaHumansMedicine0501 psychology and cognitive sciencesAcceptance and Commitment TherapyPrecision MedicineAgedmedia_commonFibromiàlgiabusiness.industry05 social sciencesMiddle AgedModerationmedicine.diseaseMobile ApplicationsTest (assessment)SadnessAnesthesiology and Pain MedicineNeurologyPsicologiaPhysical therapyFeasibility StudiesPatient ComplianceFemaleSmartphonebusiness030217 neurology & neurosurgeryResearch Article
researchProduct

Simulation study of transcatheter heart valve implantation in patients with stenotic bicuspid aortic valve

2019

Bicuspid aortic valve (BAV) anatomy has routinely been considered an exclusion in the setting of transcatheter aortic valve implantation (TAVI) because of the large dimension of the aortic annulus having a more calcified, bulky, and irregular shape. The study aims to develop a patient-specific computational framework to virtually simulate TAVI in stenotic BAV patients using the Edwards SAPIEN 3 valve (S3) and its improved version SAPIEN 3 Ultra and quantify stent frame deformity as well as the severity of paravalvular leakage (PVL). Specifically, the aortic root anatomy of n.9 BAV patients who underwent TAVI was reconstructed from pre-operative CT imaging. Crimping and deployment of S3 fram…

MaleModels Anatomicmedicine.medical_treatment02 engineering and technology030218 nuclear medicine & medical imaging0302 clinical medicineBicuspid aortic valveBicuspid Aortic Valve DiseaseImage Processing Computer-AssistedCardiac skeletonPrecision MedicineAged 80 and overCardiac cycleSettore ING-IND/34 - Bioingegneria IndustrialeComputer Science Applicationsmedicine.anatomical_structureSurgery Computer-Assistedcardiovascular systemCardiologyFemalemedicine.symptommedicine.medical_specialtyBicuspid aortic valve0206 medical engineeringFinite Element AnalysisBiomedical EngineeringDiastoleTranscatheter Aortic Valve Replacement03 medical and health sciencesFluid-solid interactionInternal medicinePreoperative CaremedicineDeformityHumansIn patientHeart valveAgedRetrospective StudiesTranscatheter aortic valve implantationbusiness.industryStentComputational BiologyFinite-element analysiAortic Valve Stenosismedicine.disease020601 biomedical engineeringbusinessTomography X-Ray ComputedEchocardiography Transesophageal
researchProduct

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker…

2017

Abstract Background Combination chemotherapy has shown benefit in the treatment of biliary cancer and further improvements might be achieved by the addition of a biological agent. We report here the effect of chemotherapy with the monoclonal EGFR antibody panitumumab as therapy for KRAS wild-type biliary cancer. Patients and methods Patients with advanced biliary tract cancer were randomised (2:1) to receive cisplatin 25 mg/m2 and gemcitabine 1000 mg/m2 on day 1 and day 8/q3w with (arm A) or without panitumumab (arm B; 9 mg/kg BW, i.v q3w). The primary end-point was the evaluation of progression-free survival (PFS) at 6 months. Secondary end-points included objective response rate (ORR), ov…

MaleOncologyCancer ResearchTime Factorsmedicine.medical_treatmentMedizinKaplan-Meier Estimatemedicine.disease_causeDeoxycytidine0302 clinical medicineRisk FactorsGermanyAntineoplastic Combined Chemotherapy ProtocolsMedicinePrecision MedicineAged 80 and overPanitumumabAntibodies MonoclonalCombination chemotherapyMiddle AgedIsocitrate DehydrogenaseBiliary Tract NeoplasmsTreatment OutcomeOncology030220 oncology & carcinogenesisDisease ProgressionBiomarker (medicine)Female030211 gastroenterology & hepatologyKRASmedicine.drugAdultmedicine.medical_specialtyAdolescentDisease-Free SurvivalProto-Oncogene Proteins p21(ras)Young Adult03 medical and health sciencesInternal medicineBiomarkers TumorHumansPanitumumabAgedCisplatinChemotherapybusiness.industryGene Expression ProfilingGemcitabineGemcitabineClinical trialMutationCisplatinbusinessEuropean Journal of Cancer
researchProduct

Customized and non-customized live-born birth-weight curves of single and uncomplicated pregnancies from the Burgundy perinatal network. Part I – met…

2017

International audience; Objectives: To establish non-customized and customized birth-weight curves of single and uncomplicated pregnancies according to gestational age.Materials and methods: We used data for 64,173 mother-infants pairs from the Burgundy perinatal network database (France) over the period 2005-2013. A validated procedure was used to link mothers with their newborns, and maternal and fetal pathologies likely to affect birth weight were excluded. Multiple regression analysis with covariate selection was used to build a customized growth curve with maternal and fetal parameters.Results: Using this methodology, three different curves were generated: an unadjusted curve for birth…

MalePediatrics[SDV]Life Sciences [q-bio]BirthweightIntrauterine growth restrictionCommunity NetworksPerinatal networkFetal Development0302 clinical medicinePregnancyBirth WeightMedicine030212 general & internal medicineGrowth ChartsPrecision Medicineeducation.field_of_studyFetal Growth Retardation030219 obstetrics & reproductive medicineObstetricsObstetrics and GynecologyGestational ageSmall for gestational ageWeight curvesFetal WeightInfant Small for Gestational AgeGestationFemaleFranceLive BirthAdultmedicine.medical_specialtyBirth weightPopulationIntrauterine growth restrictionHospitals MaternityUltrasonography PrenatalYoung Adult03 medical and health sciencesPredictive Value of TestsCovariateHumanseducationFetus[ SDV ] Life Sciences [q-bio]business.industryInfant Newbornmedicine.diseaseReproductive MedicineCustomized chartsSmall for gestational agebusinessJournal of Gynecology Obstetrics and Human Reproduction
researchProduct

The bilateral field advantage effect in memory precision.

2018

Previous research has demonstrated that visual working memory performance is better when visual items are allocated in both left and right visual fields than within only one hemifield. This phenomenon is called the bilateral field advantage (BFA). The BFA is thought to be driven by an enhanced probability of storage, rather than by greater precision. In the present experiments, we sought to test whether the BFA can also extend to precision when the parameters of the task are modified. Using a moderate number of to-be-remembered items and 400 ms presentation time, we found better precision in the bilateral condition than in the unilateral condition. The classic BFA was still found in the for…

MalePhysiologybilateral field advantageSpeech recognitionField (computer science)Functional LateralityTask (project management)0302 clinical medicineAttentionGeneral Psychologyta51505 social sciencesmemory (cognition)General MedicinenäköhavainnotNeuropsychology and Physiological PsychologyMemory Short-TermFemaleCuesPsychologyärsykkeetColor PerceptionUniversitiesExperimental and Cognitive Psychologynäkömuisti050105 experimental psychologyworking memoryvisual working memory03 medical and health sciencesPhysiology (medical)Humans0501 psychology and cognitive sciencesModerate numberStudentsmuisti (kognitio)ta113CommunicationAnalysis of Variancebusiness.industryWorking memoryAssociation Learningkapasiteettityömuistimemory precisionMental RecallVisual Fieldsbusinessvisual memory030217 neurology & neurosurgeryPhotic StimulationQuarterly journal of experimental psychology (2006)
researchProduct

Alpha emitting nuclides in nuclear medicine theranostics.

2021

Theranostic applications with radio-isotopes currently are rapidly progressing and expand nuclear medicine application in clinical routine. Alpha emitting isotopes, in particular, have long been hypothesized to achieve relevant advances for the treatment of malignancies. Here, an overview of their properties and the knowledge of radiobiology is reviewed in view of clinical translation. Clinical evidence of radiopharmaceuticals based on alpha emitters is summarized with a focus on recent developments for treatment of metastasized castration resistant prostate cancer.Theranostische Anwendungen mit Radioisotopen machen derzeit rasche Fortschritte und erweitern den Einsatz der Nuklearmedizin in…

MaleRadiobiologybusiness.industryProstatic NeoplasmsGeneral MedicineCastration resistantClinical routineTheranostic NanomedicineClinical evidenceMedicineHumansRadiology Nuclear Medicine and imagingNuclideNuclear MedicinePrecision MedicineRadiopharmaceuticalsNuclear medicinebusinessRadionuclide ImagingNuklearmedizin. Nuclear medicine
researchProduct

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine.

2013

Objective Obesity is a mild, long-lasting inflammatory disease and, as such, could increase the inflammatory burden of rheumatoid arthritis (RA). The study aim was to determine whether obesity represents a risk factor for a poor remission rate in RA patients requiring anti–tumor necrosis factor α (anti-TNFα) therapy for progressive and active disease despite treatment with methotrexate or other disease-modifying antirheumatic drugs. Methods Patients were identified from 15 outpatient clinics of university hospitals and hospitals in Italy taking part in the Gruppo Italiano di Studio sulle Early Arthritis network. Disease Activity Score in 28 joints (DAS28), body mass index (BMI; categorized …

MaleSettore MED/16 - REUMATOLOGIAArthritisGastroenterologyReceptors Tumor Necrosis FactorEtanerceptEtanerceptArthritis RheumatoidRheumatoidMonoclonalReceptorsMedicineOutpatient clinicLongitudinal StudiesRegistriesPrecision Medicineskin and connective tissue diseasesHumanizedRemission InductionAntibodies MonoclonalIndividualized MedicineMiddle AgedTreatment OutcomeRheumatoid arthritisAntirheumatic AgentsFemaleDrugmedicine.drugmusculoskeletal diseasesmedicine.medical_specialtyAdalimumab; Aged; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthritis Rheumatoid; Dose-Response Relationship Drug; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Longitudinal Studies; Male; Middle Aged; Obesity; Precision Medicine; Receptors Tumor Necrosis Factor; Registries; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alphaAntibodies Monoclonal HumanizedAntibodiesDose-Response RelationshipRheumatologyInternal medicineAdalimumabHumansObesityRisk factorAgedDose-Response Relationship Drugbusiness.industryTumor Necrosis Factor-alphaArthritisAdalimumabmedicine.diseaseInfliximabRheumatologyInfliximabAged; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthritis Rheumatoid; Dose-Response Relationship Drug; Female; Humans; Immunoglobulin G; Individualized Medicine; Longitudinal Studies; Male; Middle Aged; Obesity; Receptors Tumor Necrosis Factor; Registries; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alphaImmunoglobulin GImmunologybusinessTumor Necrosis FactorArthritis careresearch
researchProduct